Covishield Vaccine: The Central Government has said that the decision to change the time interval between two doses of Covishield from 6-8 weeks to 12 to 16 weeks is based on scientific evidence and facts. The government had said on May 13 that it had done so by accepting the recommendations of the ‘Covid-19 Working Group’. National Technical Advisory Group on Immunization Chairman NK Arora also clarified on Tuesday. That the decision to increase the interval between two doses is based on scientific evidence and is completely transparent.
Time interval between two doses of Covishield is reduce from 12 to 16 weeks
Arora said there was no difference of opinion on the decision during the group’s meeting and the recommendation was made unanimously. The Union Health Ministry has given this information in a tweet. Accepting the recommendations of the group, the government had issued new guidelines to all union territories and states. In this, the time interval between two doses of Serum Institute of India’s Vaccine Covishield has been increased from 12 to 16 weeks.
What did Health Minister Dr. Harsh Vardhan say in his tweet?
At the same time, Union Health Minister Dr. Harsh Vardhan also tweeted and said that the decision to increase the interval between two doses of Covishield has been taken in a transparent manner on the basis of scientific data. India has the best system for estimating such health data. It is very unfortunate that even such cases are being politicized.
Also Read – 5G Smartphone 2021: So many 5G phones were launched in 2021, see features and price
Decision to increase the gap between administering 2 doses of #COVISHIELD has been taken in a transparent manner based on scientific data.
India has a robust mechanism to evaluate data.
It's unfortunate that such an important issue is being politicised!https://t.co/YFYMLHi21L
— Dr Harsh Vardhan (@drharshvardhan) June 16, 2021
The ministry said in a statement that the COVID-19 Working Group has agreed to extend the time between the two doses based on the availability of real-life evidence, particularly from the UK. However, the interval between two doses of Bharat Biotech’s Covaxin was not change. The National Expert Group on Covid-19 Vaccine Administration (NEGVAC) accepted these recommendations of the working group on 12 May. NEGGVAC is headed by NITI Aayog member VK Paul.
VK Paul said – Increasing the time period between two doses was found to be more effective in the conclusion of scientific trials.
VK Paul said in the press conference on increasing the time period between two doses. That it was found to be more effective in conclusion based on scientific tests. And that is why NTAGI accepted these recommendations. In the initial study, a two-dose interval of 4 to 6 weeks was decide on Covishield. But as more data gathered as the vaccination process accelerated. It was found that increasing the two-dose interval from 4 to 8 weeks resulted in more antibodies to the body. Made in and it was found to be more effective against the corona virus.
Also Read – Coronavirus: 62224 new corona cases were found in the last 24 hours, 2542 patients died.
SHARE
